- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05020158
The Family Talk Intervention When a Parent With Dependent Children or a Child is Severely Ill
The Family Talk Intervention in Clinical Practice When a Parent With Dependent Children or a Child is Severely Ill: An Effectiveness-implementation Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The Family Talk Intervention (FTI), also called Beardslee's Family Intervention is a manual-based complex intervention and involves families who have children aged 6-18 years. The core elements are to support the families in talking about illness-related subjects, support the parents in understanding the needs of their children and how to support them, and support the families in identifying their strengths and how best to use them.
The overall aim of this trial is to evaluate the effects and the implementation process of FTI in clinical practice when a parent or a child has a life-threatening/life-limiting illness (cancer, neurological diseases, etc.). More specifically, to examine the effects of FTI regarding family communication and psychosocial health among family members (Aim 1) and describe facilitating factors and barriers for implementing FTI in everyday clinical practice (Aim 2).
The FTI has previously been pilot-tested in the context of specialized palliative home care with promising results. In pilot-tests, an assigned interventionist was used for intervention delivery, while in this continued trial, social workers will deliver the intervention as a part of their clinical work.
This trial has a pre-post effectiveness-implementation hybrid design using mixed method. It will be placed at a children's hospital and at a university hospital in Sweden and conducted by all social workers working there (n=25). Education of social workers in working with FTI will take place during 2021 and families will be invited to the project from April 2022 and until power has been reached. Data will be collected using web-based questionnaires and interviews with families and social workers, and observations will be performed throughout the study.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Malin Lövgren, PhD
- Phone Number: +46-76-6365090
- Email: malin.lovgren@mcsh.se
Study Contact Backup
- Name: Maja Holm, PhD
- Phone Number: +46700021529
- Email: maja.holm@shh.se
Study Locations
-
-
-
Stockholm, Sweden, SE- 10061
- Recruiting
- Marie Cederschiöld University College
-
Contact:
- Malin Lövgren, PhD
- Phone Number: 0046733302789
- Email: malin.lovgren@mcsh.se
-
Sub-Investigator:
- Maja Holm, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Families that include a child with a life-threatening/life-limiting illness.
- 2-3 months should have passed since diagnosis or relapse.
- <2 members of the family need to participate
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Family Talk intervention
FTI entails six meetings, with intervals of 1-2 weeks between meetings.
Meetings 1-2 include only the parent(s) and focus on their experiences of the situation, as well as the consequences of the diagnosis for each family member.
The parent(s) will formulate the goal of the intervention.
Meeting 3: Interviews will be held with each child and includes the child's life situation.
Meeting 4 includes the parent(s) and focuses on planning the family meeting.
The children's thoughts and questions serve as a guide for the upcoming family meeting.
Meeting 5 is a family meeting and consists of questions and issues raised earlier by the family members.
Meeting 6 is a follow-up with all family members.
The meeting is guided by the family members' needs, e.g., regarding communication and parenting.
If the intervention is interrupted unexpectedly and cannot be finished as scheduled due to extraordinary circumstances, extra meetings are available (Meetings 7-11).
|
A psychosocial family-based intervention that is designed to give support to an entire family when a child has life-threatening illness.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changed family communication from Family Adaptability and Cohesion Scale IV (FACES IV)
Time Frame: At baseline (before FTI starts), after the end of FTI/three months later (follow-up 1), and six months after that (follow-up 2).
|
Measures family communication
|
At baseline (before FTI starts), after the end of FTI/three months later (follow-up 1), and six months after that (follow-up 2).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changed resilience for adults measured by the Resilience Scale (RS-14)
Time Frame: At baseline (before FTI starts), after the end of FTI/three months later (follow-up 1), and six months after that (follow-up 2).
|
Measures psychosocial health for parents/guardians and for children aged 13 years and older
|
At baseline (before FTI starts), after the end of FTI/three months later (follow-up 1), and six months after that (follow-up 2).
|
|
Changed resilience in children measured by the Resilience Scale for Children (RS-10),
Time Frame: At baseline (before FTI starts), after the end of FTI/three months later (follow-up 1), and six months after that (follow-up 2).
|
Measures psychosocial health for children aged 8-12 years
|
At baseline (before FTI starts), after the end of FTI/three months later (follow-up 1), and six months after that (follow-up 2).
|
|
Changed symptoms of pathologic grief measured by Prolonged Grief Disorder (PG-12)
Time Frame: At baseline (before FTI starts), after the end of FTI/three months later (follow-up 1), and six months after that (follow-up 2).
|
Measures pre-death grief
|
At baseline (before FTI starts), after the end of FTI/three months later (follow-up 1), and six months after that (follow-up 2).
|
|
Generalized Anxiety Disorder (GAD)
Time Frame: At baseline (before FTI starts), after the end of FTI/three months later (follow-up 1), and six months after that (follow-up 2).
|
Measures anxiety in adults
|
At baseline (before FTI starts), after the end of FTI/three months later (follow-up 1), and six months after that (follow-up 2).
|
|
Changed feelings of strength and weaknesses in children measured by The Strengths and Difficulties Questionnaire (SDQ)
Time Frame: At baseline (before FTI starts), after the end of FTI/three months later (follow-up 1), and six months after that (follow-up 2).
|
Measures self-perceived strength and weakness.
Parent Proxy for children under 11 years.
|
At baseline (before FTI starts), after the end of FTI/three months later (follow-up 1), and six months after that (follow-up 2).
|
|
Changed feelings of parental skill measured by the Parental Skill Questionnaire (SDQ)
Time Frame: At baseline (before FTI starts), after the end of FTI/three months later (follow-up 1), and six months after that (follow-up 2).
|
Measures self-perceived parental skill
|
At baseline (before FTI starts), after the end of FTI/three months later (follow-up 1), and six months after that (follow-up 2).
|
|
Changed key mechanisms to promote and inhibit implementation measured by The Swedish Normalization Process Theory Measure (S-NoMAD)
Time Frame: At baseline (after FTI education), four months later (follow-up 1) and 12 months later (follow-up 2).
|
Characterizes and explains key mechanisms that promote and inhibit the implementation, embedding and integration of new health techniques, technologies and other complex interventions.
|
At baseline (after FTI education), four months later (follow-up 1) and 12 months later (follow-up 2).
|
|
Changed organizational context measured by Alberta Context Tool (ACT)
Time Frame: At baseline (after FTI education), four months later (follow-up 1) and 12 months later (follow-up 2).
|
Measures organizational context for use in complex healthcare settings.
|
At baseline (after FTI education), four months later (follow-up 1) and 12 months later (follow-up 2).
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Malin Lövgren, PhD, Ersta Sköndal Bräcke University College
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Marie Cederschiöld
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Illness Terminal
-
David BlumZurich University of Applied SciencesRecruitingTerminal Illness | Terminal CancerSwitzerland
-
University of ZurichRecruitingTerminal Illness | Terminal CancerSwitzerland
-
Bausch Health Americas, Inc.Completed
-
University College, LondonImperial College London; Brunel University; Marie Curie Hospice, Belfast; Hull...Completed
-
Ersta Sköndal University CollegeForteRecruiting
-
Bausch Health Americas, Inc.Completed
-
National Cancer Center, KoreaCompletedTerminal IllnessKorea, Republic of
-
Yvan Beaussant, MD, MSciHeffter Research Institute; Usona Institute; Oppenheimer Family Psychosocial... and other collaboratorsCompletedTerminal Illness | Psychotherapy | Psilocybin | Hospice | Demoralization | Cancer-related Problem/Condition | Terminal Cancer | Cancer TerminalUnited States
-
University College, LondonCardiff UniversityNot yet recruiting
-
University College, LondonRadboud University Medical Center; University of Bologna; Imperial College London and other collaboratorsCompletedPalliative Care | Terminal IllnessNetherlands, Belgium, Italy, Switzerland, Germany, United Kingdom
Clinical Trials on Family Talk Intervention
-
Ersta Sköndal University CollegeCompleted
-
Mental Health Services in the Capital Region, DenmarkTrygFonden, Denmark; Sektion for Tværsektoriel forskning - Region HovedstadenActive, not recruitingChild | Parenting | Resilience | Mental Disorder | Prevention | FamilyDenmark
-
Ersta Sköndal University CollegeCompletedPalliative CareSweden
-
Ersta Sköndal University CollegeForteRecruiting
-
Boston Medical CenterNational Institute on Drug Abuse (NIDA)WithdrawnSubstance Use Disorders
-
Ray HershbergerNational Heart, Lung, and Blood Institute (NHLBI); National Human Genome Research...Active, not recruiting
-
Brown UniversityNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)Recruiting
-
University of GuelphCanadian Institutes of Health Research (CIHR); Western University; Society of...Completed
-
JHSPH Center for Clinical TrialsNational Cancer Institute (NCI)Enrolling by invitationCancer | Mobile Application | Social Support (Formal and Informal)United States
-
The University of Hong KongLok Sin Tong Benevolent Society, KowloonCompleted